Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Anti-PD-L1 Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

Potential Targets in Muscle-Invasive Bladder Cancer

March 27th 2015

Treating Relapsed Muscle-Invasive Bladder Cancer

March 27th 2015

Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

March 27th 2015

Multidisciplinary Approach in Muscle-Invasive Bladder Cancer

March 27th 2015

Neoadjuvant and Adjuvant Therapy in Bladder Cancer

March 27th 2015

Managing Renal Pelvis Transitional Cell Carcinoma

March 27th 2015

Lymph Node Dissection in Bladder Cancer

March 27th 2015

Introduction: Neoadjuvant Chemotherapy in Bladder Cancer

March 27th 2015

Advanced Bladder Cancer Increases Suicide Risk, Study Says

March 27th 2015

Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report.

Genetic Testing in RCC

March 26th 2015

Immune Checkpoint Inhibition in RCC

March 26th 2015

Second-Line Cabozantinib in mRCC

March 26th 2015

Second-Line Treatments in RCC

March 26th 2015

Investigational Approaches in RCC

March 26th 2015

VEGF Versus mTOR in Non-Clear Cell RCC

March 26th 2015

Sunitinib Versus Pazopanib in Renal Cell Carcinoma

March 26th 2015

Managing Untreated Metastatic Renal Cell Carcinoma

March 26th 2015

Role of Radiation Therapy in Renal Cell Carcinoma

March 26th 2015

Introduction: Surgical Approaches in mRCC

March 26th 2015